As of 4:00pm ET
| +0.03 / +1.57%|
The 7 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 17.00 and a low estimate of 4.00. The median estimate represents a +260.82% increase from the last price of 1.94.
The current consensus among 7 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.